These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16892313

  • 1. A rapid, high content, in vivo model of glucocorticoid-induced osteoporosis.
    Barrett R, Chappell C, Quick M, Fleming A.
    Biotechnol J; 2006 Jun; 1(6):651-5. PubMed ID: 16892313
    [Abstract] [Full Text] [Related]

  • 2. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH, Werth VP.
    Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
    [Abstract] [Full Text] [Related]

  • 3. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
    Tanana I, Oshima H.
    Clin Calcium; 2006 Nov; 16(11):1851-7. PubMed ID: 17079852
    [Abstract] [Full Text] [Related]

  • 4. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH, Werth VP.
    Semin Cutan Med Surg; 2006 Jun; 25(2):72-8. PubMed ID: 16908396
    [Abstract] [Full Text] [Related]

  • 5. Barriers in the management of glucocorticoid-induced osteoporosis.
    Guzman-Clark JR, Fang MA, Sehl ME, Traylor L, Hahn TJ.
    Arthritis Rheum; 2007 Feb 15; 57(1):140-6. PubMed ID: 17266078
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN.
    Minerva Med; 2008 Feb 15; 99(1):23-43. PubMed ID: 18299694
    [Abstract] [Full Text] [Related]

  • 7. Gu Sui Bu (Drynaria fortunei J. Sm.) antagonizes glucocorticoid-induced mineralization reduction in zebrafish larvae by modulating the activity of osteoblasts and osteoclasts.
    Peng CH, Lin WY, Li CY, Dharini KK, Chang CY, Hong JT, Lin MD.
    J Ethnopharmacol; 2022 Oct 28; 297():115565. PubMed ID: 35863613
    [Abstract] [Full Text] [Related]

  • 8. Possible mechanisms of prednisolone-induced osteoporosis in zebrafish larva.
    He H, Wang C, Tang Q, Yang F, Xu Y.
    Biomed Pharmacother; 2018 May 28; 101():981-987. PubMed ID: 29635908
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoid-induced osteoporosis.
    Berris KK, Repp AL, Kleerekoper M.
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec 28; 14(6):446-50. PubMed ID: 17982350
    [Abstract] [Full Text] [Related]

  • 10. Effects of anti-osteoporosis drugs against dexamethasone-induced osteoporosis-like phenotype using a zebrafish scale-regeneration model.
    Saito Y, Nakamura S, Chinen N, Shimazawa M, Hara H.
    J Pharmacol Sci; 2020 Jun 28; 143(2):117-121. PubMed ID: 32220570
    [Abstract] [Full Text] [Related]

  • 11. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
    Tanaka I, Oshima H.
    Clin Calcium; 2007 Nov 28; 17(11):1738-44. PubMed ID: 17982195
    [Abstract] [Full Text] [Related]

  • 12. Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city.
    Caballero-Uribe CV, Acosta-Velez JG, Hernandez-Ruiz EA, Andrade Rodado FM, Peñuela-Epalza M.
    J Clin Rheumatol; 2008 Jun 28; 14(3):153-5. PubMed ID: 18525434
    [Abstract] [Full Text] [Related]

  • 13. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment].
    Tanaka H.
    Clin Calcium; 2007 Jul 28; 17(7):1114-9. PubMed ID: 17607080
    [Abstract] [Full Text] [Related]

  • 14. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
    Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG.
    Arch Intern Med; 2007 Mar 26; 167(6):591-6. PubMed ID: 17389291
    [Abstract] [Full Text] [Related]

  • 15. [Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)].
    Masaki H, Miki T.
    Clin Calcium; 2006 Nov 26; 16(11):1823-32. PubMed ID: 17079849
    [Abstract] [Full Text] [Related]

  • 16. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Doga M, Mazziotti G, Bonadonna S, Patelli I, Bilezikian JP, Canalis E, Giustina A.
    J Endocrinol Invest; 2008 Jul 26; 31(7 Suppl):53-8. PubMed ID: 18791353
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM, Valeriano J, Vasey FB, Carter JD.
    J Clin Rheumatol; 2006 Oct 26; 12(5):221-5. PubMed ID: 17023807
    [Abstract] [Full Text] [Related]

  • 18. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S.
    Clin Calcium; 2009 Jan 26; 19(1):44-53. PubMed ID: 19122264
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
    Migliaccio S, Brama M, Fornari R, Greco EA, Spera G, Malavolta N.
    Aging Clin Exp Res; 2007 Jun 26; 19(3 Suppl):5-10. PubMed ID: 18180599
    [Abstract] [Full Text] [Related]

  • 20. [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis].
    Takeuchi Y.
    Clin Calcium; 2009 Jan 26; 19(1):85-90. PubMed ID: 19122268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.